Improved fix-mutant proteins for hemophilia B treatment

Details for Australian Patent Application No. 2008209985 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Dockal, Michael; Hartmann, Rudolf; Scheiflinger, Friedrich

Agent Cullen & Co

Pub. Number AU-A-2008209985

PCT Pub. Number WO2008/092643

Priority 60/898,876 01.02.07 US

Filing date 29 January 2008

Wipo publication date 7 August 2008

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/092643 Priority application(s): WO2008/092643

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209986-FVIII-independent FIX-mutant proteins for hemophilia A treatment

2008209981-Resealable container for storing moisture sensitive test elements